1.02

4.67% 0.0455

After Hours: 1.01 -0.01 -0.98%

Tiziana Life Sciences Ltd (TLSA)

Overview News Price History Option Chain Discussions Forecast Stock Split

Tiziana Life Sciences Ltd stock is traded at $1.02, with a volume of 573.92K. It is up +4.67% in the last 24 hours and up +5.42% over the past month. Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.

Previous Close:

$0.9745

Open:

$0.972

24h Volume:

573.92K

Relative Volume:

1.05

Market Cap:

$129.80M

Revenue:

Net Income/Loss:

$-18.43M

P/E Ratio:

-6.5469

EPS:

-0.1558

Net Cash Flow:

$-12.87M

1W Performance:

+0.99%

1M Performance:

+5.42%

6M Performance:

-28.67%

1Y Performance:

-35.44%

1-Day Range:

$0.9507

$1.06

1-Week Range:

$0.91

$1.06

52-Week Range:

$0.8663

$2.35

Tiziana Life Sciences Ltd Stock (TLSA) Company Profile

Name

Tiziana Life Sciences Ltd

Sector

Healthcare (1074)

Industry

Biotechnology (600)

Phone

Address

Employee

Twitter

@tizianals

Next Earnings Date

2026-08-07

Latest SEC Filings

TLSA's Discussions on Twitter

Compare TLSA vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TLSA Tiziana Life Sciences Ltd	1.02	142.53M	0	-18.43M	-12.87M	-0.1558
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Tiziana Life Sciences Ltd Stock (TLSA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-22-20	Initiated	B. Riley Securities	Buy
Dec-17-18	Initiated	Laidlaw	Buy

Tiziana Life Sciences Ltd Stock (TLSA) Latest News

Sep 03, 2026

Small cap wrap: Tiziana Life Sciences, Thistle Resources, Alvopetro, BioHarvest... - Proactive financial news

Sep 03, 2026

Tiziana Life Sciences gets Buy rating from BTIG on Treg-based approach to neurodegeneration - Proactive financial news

Sep 03, 2026

Tiziana Life Sciences initiated with a Buy at BTIG - TipRanks

Sep 03, 2026

This Occidental Petroleum Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga

Sep 03, 2026

BTIG Initiates Tiziana Life Sciences at Buy With $7 Price Target - marketscreener.com

Sep 03, 2026

BTIG initiates Tiziana Life Sciences stock with buy on MS drug - Investing.com

Sep 03, 2026

Aug 24, 2026

Wall Street ends on a mixed note as Dow gains despite semiconductor slump - Proactive financial news

Aug 24, 2026

Market movers: Strategy, Bitmine, Tiziana Life Sciences... - Proactive financial news

Aug 24, 2026

Tiziana (NASDAQ: TLSA) highlights intranasal ALS trial and MS data - Stock Titan

Aug 24, 2026

Tiziana Life Sciences Ltd. - Via Ritzau

Aug 24, 2026

Tiziana Life Sciences to present Phase 2a BANYAN trial data at ALS Nexus 2026 - Proactive financial news

Aug 24, 2026

Aug 11, 2026